Ticagrelor costs the United States over $750 million annually, yet a BMJ investigation casts new doubts on the reliability of the pivotal clinical trial that led to the drug’s approval. A new investigation published by The BMJ highlights fresh concerns about the PLATO clinical trial, a pivotal study that led to the global approval of [...]from SciTechDaily https://ift.tt/OzshP20
